covid
Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal Is P-glycoprotein relevant for the release of microvesicles by tumor cells?
Información de la revista
Vol. 2. Núm. 5.
Páginas 226 (septiembre - octubre 2017)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. 5.
Páginas 226 (septiembre - octubre 2017)
PS212
Open Access
Is P-glycoprotein relevant for the release of microvesicles by tumor cells?
Visitas
1647
I. Castro1,2,3,
Autor para correspondencia
msilva@ipatimup.pt

Corresponding author.
, C.P.R. Xavier1,2, M.H. Vasconcelos1,2,4
1 i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
2 Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, 4200-465 Porto, Portugal
3 FMUP – Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
4 FFUP – Faculty of Pharmacy of the University of Porto, 4050-313 Porto, Portugal
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

Aim: In this study, we aimed to verify if MDR cells without expression of P-gp also produced more microvesicles and less exosomes than their DS counterpart cells.

Introduction: Cancer multidrug resistance (MDR) is a major cause of chemotherapy failure and is highly associated with overexpression of drug-efflux pumps such as P-glycoprotein (P-gp). The identification of mechanisms specific of P-gp overexpressing cells may contribute to the identification of biomarkers of MDR.

It was recently discovered that a drug-resistant phenotype may be horizontally transferred from drug-resistant (DR) to drug-sensitive (DS) cells, mediated by the cargo of extracellular vesicles (EVs) released by DR cells and captured by DS cells. These EVs include smaller exosomes and larger microvesicles. Our previous work showed that MDR cells with overexpression of P-gp released more microvesicles than exosomes, unlike their DS counterpart cells. However, it is not known if this phenomenon is restricted to MDR cells with overexpression of P-gp or if it is extensive to all DR cells (with other mechanism of drug resistance).

Methods: Drug-response curves of MDR and DS counterpart cells were obtained, using resazurin and trypan blue assays, to confirm the resistant or sensitive phenotype of the cell lines. Confirmation of their P-gp status was possible by Western-Blot. EVs released by both DS and MDR cells were isolated by ultracentrifugation and characterized by transmission electron microscopy, dynamic light scattering, nanoparticle tracking analysis and Western blot analysis.

Results: We confirmed that MDR cells without expression of P-gp release EVs with similar sizes to the ones released by their DS counterparts.

Conclusion: So, P-gp may be associated with the release of larger EVs by MDR cells. These results will be further confirmed by characterizing the EVs released by P-gp overexpressing MDR cell lines following downregulation of P-gp expression and the EVs released by DS cell lines following transfection of P-gp.1–4

References
[1]
Z. Chen, et al.
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade.
Cancer Lett, 370 (2016), pp. 153-164
[2]
D. Sousa, R.T. Lima, M.H. Vasconcelos.
Intercellular transfer of cancer drug resistance traits by extracellular vesicles.
Trends Mol Med, 21 (2015), pp. 595-608
[3]
V. Lopes-Rodrigues, et al.
Data supporting the shedding of larger extracellular vesicles by multidrug resistant tumour cells.
Data Brief, 6 (2016), pp. 1023-1027
[4]
V. Lopes-Rodrigues, et al.
Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
Biochim Biophys Acta, 1860 (2016), pp. 618-627
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos